A revolution in cancer treatment could soon be underway following a breakthrough that may lead to a dramatic improvement in cancer survival rates.
A new study at the University of Warwick, published today in the journal Angewandte Chemie International Edition, has developed a new drug that can manipulate the body’s natural signalling and energy systems, allowing the body to attack and shut down cancerous cells.
Called ZL105, the drug is a compound based on the precious metal iridium. The study has found ZL105 could potentially replace currently used anticancer drugs, which become less effective over time, cause a wide-range of side-effects and damage healthy cells as well as cancerous.
Commenting on the breakthrough, University of Warwick researcher and study co-author Dr Isolda Romero-Canelon said “The energy-producing machinery in cancer cells works to the limit as it attempts to keep up with quick proliferation and invasion. This makes cancer cells susceptible to minor changes in the cell ‘power-house’. Our drug pushes cancer cells over the limit causing them to slow and shut down, whilst normal cells can cope with its effects”.
Preliminary data indicate that the novel drug may be ten times more effective in treating ovarian, colon, melanoma, renal, and some breast cancers, according to data obtained by the US National Cancer Institute. The researchers now aim to expand the study to cancers that are inherently resistant to existing drugs and to those which have developed resistance after a first round of chemotherapy treatments.
Study co-author Professor Peter J. Sadler said “Existing cancer treatments often become less effective after the first course, as cancer cells learn how they are being attacked. The drug we have developed is a catalyst and is active at low doses. It can attack cancer cells in multiple ways at the same time, so the cancer is less able to adapt to the treatment. This means the new drugs could be much more effective than existing treatments.”
“Platinum-based drugs are used in nearly 50% of all chemotherapeutic regimens, exert their activity by damaging DNA and cannot select between cancerous and non-cancerous cells, leading to a wide-range of side-effects from renal failure to neurotoxicity, ototoxicity, nausea and vomiting.
“In contrast, the new iridium-based drug is specifically designed not to attack DNA, but to have a novel mechanism of action, meaning that it could not only dramatically slow down and halt cancer growth, but also significantly reduce the side effects suffered by patients” argues Professor Sadler.
This research could also lead to substantial improvements in cancer survival rates. “Current statistics indicate that one in every three people will develop some kind of cancer during their life time, moreover approximately one woman dies of ovarian cancer every two hours in the UK according to Cancer Research UK .It is clear that a new generation of drugs is necessary to save more lives and our research points to a highly effective way of defeating cancerous cells” said Dr Romero-Canelon.
The Latest on: Cancer treatment
[google_news title=”” keyword=”Cancer treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer treatment
- Dave Myers - updates: Si King leads tributes as Hairy Bikers co-star dies after cancer diagnosison March 1, 2024 at 6:19 am
TV chef Dave Myers, one half of the Hairy Bikers, has died at the age of 66, according to a statement shared this morning by his co-star and close friend Si King.He found fame alongside King, his best ...
- Surviving Brain Cancer: Those Who Live Longon March 1, 2024 at 6:00 am
Glioblastoma (GBM) is a rare and deadly disease: roughly 12,000 new patients are diagnosed every year in the US, a country of 330 million people. Most GBM patients die within 15 months and fewer than ...
- Pancreatic Cancer Treatment: 6 Dietary Guidelines to Reduce The Risk of Deadly Diseaseon March 1, 2024 at 5:41 am
People diagnosed with Pancreatic cancer often find it difficult to maintain their weight and follow a healthy diet. This highly aggressive disease is rarely diagnosed at an early stage and is ...
- The Hope And Unkept Promise Of Brain Cancer Clinical Trialson March 1, 2024 at 5:00 am
Clinical trials stand out in the bleak landscape of GBM treatment, where patients typically receive surgery, followed by a regimen of chemotherapy drugs and radiotherapy.
- Browns play-by-play voice Jim Donovan has completed his cancer treatmentson February 29, 2024 at 3:02 pm
CLEVELAND, Ohio -- Thursday morning started off with the best kind of news regarding the radio play-by-play voice of the Browns, Jim Donovan. He rang the bell three times at University Hospital to ...
- Colorectal cancer screening and early detection are key to effective treatmenton February 29, 2024 at 1:53 pm
With more proactive screening and advanced treatment options, the death rate associated with colorectal cancer has dropped.
- New research on prostate cancer may lead to better diagnostics, treatmentson February 28, 2024 at 3:59 pm
Researchers are reporting that a program aided by artificial intelligence (AI) has helped them identify two distinct subtypes of prostate cancer — a finding they say could improve diagnosis and ...
- Man in remission from blood cancer and HIV after remarkable treatmenton February 28, 2024 at 10:37 am
Paul Edmonds of California is fifth-known person in world confirmed to be in remission from both, says cancer institute ...
- Cancer treatment in UK lags behind other comparable countries, study sayson February 28, 2024 at 2:55 am
The UK lagged behind other similar countries in cancer treatment, with patients waiting longer before starting chemotherapy, according to two new studies. Researchers analysed data from more than ...
- ‘Pioneering’ breakthrough paves way for new breast cancer treatmenton February 28, 2024 at 1:36 am
A breakthrough injection could pave the way for a pioneering new treatment for breast cancer, which kills thousands of women every year. Scientists have found a way to use a new cancer treatment, ...
via Bing News